Wa Ilunga E N, Muya R K, Kaponda A A, Kaput C M A, Kalonji S M, Chiribagula V B, Nshikala B N, N'sasi A N, Simbi J-B L
Faculté des sciences pharmaceutiques, département de pharmacologie, université de Lubumbashi (UNILU), B.P. 1825, Lubumbashi, Haut-Katanga, Congo; Faculté des sciences, département de chimie, UNILU, Lubumbashi, Haut-Katanga, Congo.
Faculté des sciences pharmaceutiques, département de pharmacologie, université de Lubumbashi (UNILU), B.P. 1825, Lubumbashi, Haut-Katanga, Congo.
Rev Pneumol Clin. 2018 Feb;74(1):9-15. doi: 10.1016/j.pneumo.2017.12.002. Epub 2018 Jan 9.
Tuberculosis and HIV/AIDS are a dangerous couple in sub-Saharan Africa. The aim of this paper is to evaluate the prevalence of the co-infection tuberculosis/HIV/AIDS and its impact on issues of tuberculosis patients treated in Lubumbashi Heath Zone (LHZ).
A retrospective and transversal study was conducted through the analysis of tuberculosis patients' data admitted in the tuberculosis Health Centers for Diagnosis and treatment (HCDT) in the LHZ from January 2014 to December 2015. TB-HIV co-infection cases will be identified and the outcome will be analyzed.
Data of 1368 patients were noted from three HCDT of the TB of the Lubumbashi ZS and among them 334 cases of co-infections were recorded. The most incriminated age range is 40-50 years. The mean of age of our patients is 32.84±15.32 years and the man/women sex ratio is 1.70. The most predominant clinical tuberculosis form is the extra pulmonary [EPT (52.70 %)]. Among co-infected patients, the predominant form is pulmonary (TPM-). Out of the 51 cases of deaths recorded, 23 (45.10 %) also had HIV while 28 (54.90 %) were HIV-negative. There was an increase of 11.6 % in TB-HIV/AIDS co-infection from 2014 to 2015.
TB-HIV/AIDS co-infection is a reality in the LHZ, especially in patients with negative bacterial TB (TPM-) and we have to pay a particular attention on the impact of HIV on the death of tuberculosis patients.
在撒哈拉以南非洲地区，结核病与艾滋病毒/艾滋病是一对危险组合。本文旨在评估结核病/艾滋病毒/艾滋病合并感染的患病率及其对卢本巴希健康区（LHZ）接受治疗的结核病患者相关问题的影响。
通过分析2014年1月至2015年12月在LHZ结核病诊断与治疗健康中心（HCDT）收治的结核病患者数据，开展了一项回顾性横断面研究。将识别结核病 - 艾滋病毒合并感染病例并分析结果。
从卢本巴希ZS的三个结核病HCDT记录了1368例患者的数据，其中记录了334例合并感染病例。最主要的年龄范围是40 - 50岁。我们患者的平均年龄为32.84±15.32岁，男女比例为1.70。最主要的临床结核病形式是肺外结核[EPT（52.70%）]。在合并感染患者中，主要形式是肺结核（TPM -）。在记录的51例死亡病例中，23例（45.10%）也感染了艾滋病毒，28例（54.90%）艾滋病毒检测呈阴性。2014年至2015年，结核病 - 艾滋病毒/艾滋病合并感染增加了11.6%。
结核病 - 艾滋病毒/艾滋病合并感染在LHZ是一个现实情况，尤其是在痰菌阴性的结核病（TPM -）患者中，我们必须特别关注艾滋病毒对结核病患者死亡的影响。
